MIRROR, NCT06074510: PYLARIFY® PET/CT or PET/MRI in Men with Favorable Intermediate Risk (FIR) Prostate Cancer |
|
|
| Recruiting | 4 | 274 | US | Piflufolastat F 18 Intravenous Solution [PYLARIFY], PYLARIFY, 18F-DCFPyL | Lantheus Medical Imaging | Prostate Cancer | 11/26 | 11/26 | | |
NCT05048732: Imaging Apoptosis for Lymphoma Treatment Response |
|
|
| Terminated | 1 | 12 | US | 18F-FluorApoTrace, 18F-FAT | Washington University School of Medicine, AbbVie | Diffuse Large B Cell Lymphoma | 02/24 | 02/24 | | |